financetom
Business
financetom
/
Business
/
Tinder owner Match to cut staff by about 8% after downbeat forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tinder owner Match to cut staff by about 8% after downbeat forecast
Feb 1, 2023 12:35 PM

Match Group Inc said on Wednesday it would lay off about 8 percent of its workforce, a day after it forecast first-quarter revenue below Wall Street expectations.

Share Market Live

NSE

The company has already cut jobs in the United States and the process is ongoing in other countries, Chief Financial Officer Gary Swidler said on the earnings call.

Shares of the Texas-based firm were down 7.8 percent, having lost 11 percent after the bell on Tuesday following its downbeat forecast.

The dating company joins Big Tech firms and Wall Street titans in reducing staff as they strive to cut costs amid concerns of a recession.

Match said on Tuesday it expected to incur about $6 million in severance and similar expenses in 2023, adding that its cost cuts will help improve margins in the second half of the year.

Also Read:

Meta layoffs: More job cuts likely? Here’s what Mark Zuckerberg told employees

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novartis Gets FDA Accelerated Approval for Vanrafia
Novartis Gets FDA Accelerated Approval for Vanrafia
Apr 3, 2025
04:41 AM EDT, 04/03/2025 (MT Newswires) -- Novartis ( NVS ) said late Wednesday the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression. IgAN is a progressive, rare kidney disease. Data from an ongoing phase III showed that Vanrafia achieved...
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate
Apr 3, 2025
04:23 AM EDT, 04/03/2025 (MT Newswires) -- Mesoblast (MESO) said late Wednesday it expets to have a type B meeting with the US Food and Drug Administration during the current quarter to discuss the accelerated approval pathway for ischemic heart failure treatment candidate, Revascor. The main goals of the meeting are to get FDA feedback on relevant chemistry, manufacturing &...
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says
Apr 3, 2025
04:35 AM EDT, 04/03/2025 (MT Newswires) -- The slate of tariffs from the Trump administration is worse than the worst case scenario feared by analysts, according to Wedbush Securities. In a note emailed to clients on Wednesday, Wedbush analysts, led by Daniel Ives, said tech stocks will be under major pressure following the announcement. On Wednesday, the Trump administration unveiled...
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Traders seek refuge in Aussie consumer staples as US tariffs spark market fall
Apr 3, 2025
By Rajasik Mukherjee (Reuters) - Shares of Australia's consumer staple companies rose on Thursday, driven by grocers Coles and Woolworths, as investors moved to safer bets after U.S. President Donald Trump's reciprocal tariffs sparked global market turmoil. Shares of the sector ended 1.3% higher while the broader Australian market fell 0.9% to its lowest since March 14. Coles rose 2.1%...
Copyright 2023-2025 - www.financetom.com All Rights Reserved